Friday, July 20, 2007 11:06:42 AM
Looking through history, Nucryst put their cream through phase II which ended in September of last year. The results of the study are here...
http://www.nucryst.com/current_releases/pr_9202006.htm
Looking at it, their cream did no better at healing dermatitis than placebo! So what good is it? They developed this cream, put their heads together and determined their best shot was dermatitis for clinical trials and then found it was no better than placebo. However, it was determined to be safe so they get FDA approval, apparently while they try to find out an actual worthwhile use for the cream.
I don't have anything against the company and they seem like good, honest people but they seem to be stuck with a very questionable product.
I'm guessing this >100% one-day gain so far today is largely the result that it's 11:00 am and the entire float has already traded. If it moves up more today, it will probably again be largely to the volume trading. I wouldn't buy the stock at this point.
FEATURED POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • May 14, 2024 10:09 AM
FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM
VAYK Added New Manager for Expansion into $64 Billion Domestic Short-term Rental Market • VAYK • May 14, 2024 9:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM